Aurora Cannabis (ACB) Assets (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Assets of $438.3 million for Q1 2026, down 26.24% year-on-year from $594.2 million in Q1 2025, and down 21.16% on a QoQ basis from $556.0 million in Q4 2025.
Aurora Cannabis (ACB) Assets (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Assets for 9 consecutive years, with $438.3 million the latest figure, recorded in Q1 2026.
- Quarterly Assets fell 26.24% year-over-year to $438.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $438.3 million (down 26.24% YoY) and the FY2026 annual result came in at $435.0 million, down 29.09% from the prior year.
- Assets retreated to $438.3 million in Q1 2026 per ACB's latest filing, from $556.0 million in the prior quarter.
- Over the last five years, Assets for ACB reached as high as $1.2 billion in Q1 2022 and fell as low as $438.3 million in Q1 2026.
- A 5-year average of $673.2 million and a median of $612.2 million in 2024 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets plunged 61.75% — and 2024, when it grew 2.84%.
- Year by year, Assets stood at $754.3 million in 2022, then decreased by 20.42% to $600.2 million in 2023, then grew by 2.84% to $617.3 million in 2024, then decreased by 9.93% to $556.0 million in 2025, then declined by 21.16% to $438.3 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $438.3 million, $556.0 million, and $550.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.40 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.04 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.15 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 98.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.71 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 69.30 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 36.83 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.91 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.22 Bn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 438.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 438.32 Mn |
| Dec 31, 2025 | 555.95 Mn |
| Sep 30, 2025 | 549.96 Mn |
| Jun 30, 2025 | 604.68 Mn |
| Mar 31, 2025 | 594.24 Mn |
| Dec 31, 2024 | 617.27 Mn |
| Sep 30, 2024 | 591.86 Mn |
| Jun 30, 2024 | 612.18 Mn |
| Mar 31, 2024 | 622.39 Mn |
| Dec 31, 2023 | 600.24 Mn |
| Sep 30, 2023 | 610.45 Mn |
| Jun 30, 2023 | 619.52 Mn |
| Mar 31, 2023 | 685.20 Mn |
| Dec 31, 2022 | 754.26 Mn |
| Sep 30, 2022 | 897.04 Mn |
| Jun 30, 2022 | 850.50 Mn |
| Mar 31, 2022 | 1.24 Bn |
| Dec 31, 2021 | 1.97 Bn |
| Sep 30, 2021 | 2.03 Bn |
| Jun 30, 2021 | 2.12 Bn |